About: Placebo-controlled trials and the Declaration of Helsinki

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Placebo-controlled trials and the Declaration of Helsinki Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 13 April 2002)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2002 (ast) vědecký článek publikovaný v roce 2002 (cs) 2002 թվականի ապրիլին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована у квітні 2002 (uk) 2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած (hyw) ശാസ്ത്രപ്രബന്ധം (ml) im April 2002 veröffentlichter wissenschaftlicher Artikel (de) article publié dans la revue scientifique The Lancet (fr) مقالة علمية (نشرت في 13-4-2002) (ar) vedecký článok (publikovaný 2002/04/13) (sk) wetenschappelijk artikel (gepubliceerd op 2002/04/13) (nl) scientific article (publication date: 13 April 2002) (en)
publication date	wds:Q28215315-0C4BB44C-5B49-4173-9BC0-E704392DDE2A
publication date	2002-04-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28215315-918179B0-D0B4-4B0C-B629-DDDBE3A0D599
language of work or name	English
cites work	wds:Q28215315-1D466129-9D66-4599-B751-22F46B6B5C05 wds:Q28215315-41BF81A8-7C0B-4273-BA5D-8E2476AD11F3 wds:Q28215315-47555F7A-296B-4342-BE33-0B04CDFAF872 wds:Q28215315-5E9EBFFB-DA75-43C2-8AF2-4A4B69F91C6C wds:Q28215315-7697F5B6-E49C-4A6C-8F66-C6B4C3671282 wds:Q28215315-A04BD859-3585-4C59-AF88-547BFF531315 wds:Q28215315-E6CED658-B633-4594-9E2A-ED521CE33BD0 wds:Q28215315-EA090BD6-A2E7-4C56-885F-37DD1B7D82A0 wds:Q28215315-FDAA0867-28E2-4F7A-9C70-8F18F096862A
cites work	Beta blockade during and after myocardial infarction: an overview of the randomized trials Doctors revise declaration of Helsinki Ethical issues in the design and conduct of clinical trials in developing countries The continuing unethical use of placebo controls Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues Trials to assess equivalence: the importance of rigorous methods Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study Research involving human subjects in developing countries. Placebos on trial
author name string	wds:Q28215315-2E7B8E40-ACC7-4BE2-B272-A0F9A2536807 wds:Q28215315-2FE19D35-BD45-4C9A-B832-2C5F2BBB4098 wds:Q28215315-747AF9F9-8172-45B3-BE19-74C796738D36 wds:Q28215315-B9163AE5-D377-4EA3-B906-5596E0911CC1
author name string	John A Lewis Gottfried Kreutz Bertil Jonsson Barbara van Zwieten-Boot
rdfs:label	Placebo-controlled trials and the Declaration of Helsinki (en) Placebo-controlled trials and the Declaration of Helsinki (nl) Placebo-controlled trials and the Declaration of Helsinki (ast)
skos:prefLabel	Placebo-controlled trials and the Declaration of Helsinki (en) Placebo-controlled trials and the Declaration of Helsinki (nl) Placebo-controlled trials and the Declaration of Helsinki (ast)
name	Placebo-controlled trials and the Declaration of Helsinki (en) Placebo-controlled trials and the Declaration of Helsinki (nl) Placebo-controlled trials and the Declaration of Helsinki (ast)
author	wds:Q28215315-865E4D35-51C2-4868-A84C-782F5BECC75B
author	Cristina Sampaio
title	wds:Q28215315-49738834-213E-4C6C-86A8-0D55016FA544
title	Placebo-controlled trials and the Declaration of Helsinki (en)
page(s)	wds:Q28215315-E302081C-6DC3-4BCD-BE9A-23FC5C2C0192
page(s)	1337-40
instance of	wds:Q28215315-1A9E1116-ACD4-4834-99E0-E1A244615240
instance of	scholarly article
main subject	wds:Q28215315-100A28F2-84D9-43DD-9411-4BC374182BC8
main subject	placebo
PubMed ID	wds:Q28215315-80FCB5EF-5B55-4621-B1D9-EF2DA4995EC0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11965296
PubMed ID	11965296
published in	wds:Q28215315-F50783BE-10A0-4770-A647-37C294216CB3
published in	The Lancet
issue	wds:Q28215315-51D1D29C-86EF-4F0A-BD54-125CE7A55172
volume	wds:Q28215315-BD7BD087-582E-4282-A6B7-DF4293C2DB85
issue	9314
volume	359
DOI	wds:Q28215315-D5BB02C8-3A7A-406F-9E0A-D95014132C3F
DOI	http://dx.doi.org/10.1016/S0140-6736(02)08277-6
DOI	10.1016/S0140-6736(02)08277-6
is owl:sameAs of	Placebo-controlled trials and the Declaration of Helsinki
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28215315
is cites work of	Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis Concerns about injectable naltrexone for opioid dependence Clinical significance of the placebo effect A comparison of multiple testing procedures for the gold standard non-inferiority trial. Clinical trials in systemic lupus erythematosus: a status report on ongoing trials. Uncertainty and the ethics of clinical trials Consent to open label extension studies: some ethical issues Measuring the efficacy of antiepileptic drugs Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies: which is better? Placebo and the Helsinki Declaration--what to do? Effects of repetitive transcranial magnetic stimulation on clinical, social, and cognitive performance in postpartum depression Ethical aspects of the relationship of dermatology and industry: the Independent Ethics Committee The case for statins: has it really been made? The three official language versions of the Declaration of Helsinki: what's lost in translation? Challenges and opportunities: what we are learning from the clinical natalizumab experience Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No. How can research ethics committees protect patients better? Placebo treatment is effective differently in different diseases--but is it also harmless? A brief synopsis Superior efficacy of new medicines? Ethics of testing drugs with readily available alternatives. Content and Classffication of Clinical Trials at a University Hospital in Japan Study designs, duration, and choice of comparators including the use of placebo.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software